Drug Profile
Research programme: protein kinase inhibitors - Netherlands Translational Research Center
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Netherlands Translational Research Center
- Class Antineoplastics
- Mechanism of Action Protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Cancer in Netherlands
- 27 Jul 2016 Early research in Cancer in Netherlands (unspecified route)